Castle Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
05 Jun 23 | BuyUS$69,004 | Ellen Goldberg | Individual | 4,800 | US$17.27 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 48,585 | 0.176% |
Individual Insiders | 764,433 | 2.77% |
General Public | 1,558,945 | 5.65% |
Institutions | 25,215,099 | 91.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,551,088 | US$51.2m | -1.54% | 0.19% | |||
2,283,199 | US$45.8m | 6.88% | no data | |||
2,166,471 | US$43.5m | -12.9% | 1.5% | |||
1,585,639 | US$31.8m | 6.98% | 0.02% | |||
1,461,481 | US$29.3m | 1.53% | no data | |||
1,232,378 | US$24.7m | 0.35% | 0.27% | |||
965,428 | US$19.4m | 1.99% | 0.4% | |||
728,653 | US$14.6m | 188% | 1.12% | |||
716,350 | US$14.4m | 20.4% | 0.01% | |||
663,980 | US$13.3m | -14.2% | 0.26% | |||
663,882 | US$13.3m | 19.5% | no data | |||
579,918 | US$11.6m | 2.61% | no data | |||
566,115 | US$11.4m | 5.57% | no data | |||
542,874 | US$10.9m | -16.3% | 0.18% | |||
539,135 | US$10.8m | -10.5% | 0.31% | |||
536,787 | US$10.8m | -1.94% | 0.05% | |||
468,252 | US$9.4m | 1,470% | no data | |||
414,990 | US$8.3m | -4.09% | no data | |||
357,156 | US$7.2m | 59% | 0.98% | |||
329,861 | US$6.6m | 0% | no data | |||
328,749 | US$6.6m | -36.5% | 0.01% | |||
326,270 | US$6.5m | 109% | 0.7% | |||
279,727 | US$5.6m | 5.16% | no data | |||
249,983 | US$5.0m | 2.52% | no data | |||
237,126 | US$4.8m | -3.56% | 0.01% |